Browse our anti-TGFB1 (TGFB1) Antibodies

Full name:
anti-Transforming Growth Factor, beta 1 Antibodies (TGFB1)
On www.antibodies-online.com are 452 Transforming Growth Factor, beta 1 (TGFB1) Antibodies from 36 different suppliers available. Additionally we are shipping TGFB1 Kits (193) and TGFB1 Proteins (116) and many more products for this protein. A total of 784 TGFB1 products are currently listed.
Synonyms:
ai39657, betaig-h3, bigh3, cdb1, cdg2, cdgg1, ced, csd, csd1, csd2, csd3, dpd1, ebmd, lap, lcd1, MGC146225, tgf, tgf-beta, TGF-BETA-1, TGF-beta1, TGF-beta5, tgfb, Tgfb-1, TGFB1, TGFB4, tgfb5, tgfbeta, TGFbeta1, TGFBI, wu:fb13a07, xx:ai39657
list all antibodies Gene Name GeneID UniProt
TGFB1 7040 P01137
TGFB1 59086 P17246
TGFB1 21803 P04202

Show all species

Show all synonyms

Most Popular Reactivities for anti-TGFB1 (TGFB1) Antibodies

Select your species and application

anti-Human TGFB1 Antibodies:

anti-Rat (Rattus) TGFB1 Antibodies:

anti-Mouse (Murine) TGFB1 Antibodies:

All available anti-TGFB1 Antibodies

Go to our pre-filtered search.

Top referenced anti-TGFB1 Antibodies

  1. Human Polyclonal TGFB1 Primary Antibody for IF (p), IHC (p) - ABIN724685 : Kou, Hu, Yao, Wang, Shen, Kang, Hong: Transforming growth factor-?1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment. in Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2013 (PubMed)
    Show all 15 references for 724685

  2. Human Polyclonal TGFB1 Primary Antibody for WB - ABIN223608 : Tamaki, Hatano, Taura, Tada, Kodama, Nitta, Iwaisako, Seo, Nakajima, Ikai, Uemoto: CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. in American journal of physiology. Gastrointestinal and liver physiology 2008 (PubMed)
    Show all 6 references for 223608

  3. Human Polyclonal TGFB1 Primary Antibody for IF, IHC (p) - ABIN656282 : Perez, Sierra, Garcia, Aguirre, Babel, Alvarez, Sanchez, Valdes, Volk, Guzman: Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. in Human immunology 2010 (PubMed)
    Show all 6 references for 656282

  4. Human Polyclonal TGFB1 Primary Antibody for EIA, IF - ABIN955174 : Bran, Sommer, Goessler, Hörmann, Riedel, Sadick: TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars. in Anticancer research 2010 (PubMed)
    Show all 5 references for 955174

  5. Human Monoclonal TGFB1 Primary Antibody for EIA, Func - ABIN114558 : Crawford, Stellmach, Murphy-Ullrich, Ribeiro, Lawler, Hynes, Boivin, Bouck: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. in Cell 1998 (PubMed)
    Show all 4 references for 114558

  6. Human Monoclonal TGFB1 Primary Antibody for FACS - ABIN4897280 : Azukizawa, Döhler, Kanazawa, Nayak, Lipp, Malissen, Autenrieth, Katayama, Riemann, Weih, Berberich-Siebelt, Lutz: Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells. in European journal of immunology 2011 (PubMed)
    Show all 4 references for 4897280

  7. Human Monoclonal TGFB1 Primary Antibody for FACS, IHC - ABIN969570 : Maeshige, Terashi, Aoyama, Torii, Sugimoto, Usami: Effect of ultrasound irradiation on α-SMA and TGF-β1 expression in human dermal fibroblasts. in The Kobe journal of medical sciences 2011 (PubMed)

  8. Human Polyclonal TGFB1 Primary Antibody for IHC, ELISA - ABIN1533412 : Matsumoto, Niimi, Kohyama: Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis. in Cellular immunology 2012 (PubMed)

  9. Human Monoclonal TGFB1 Primary Antibody for EIA, IHC (p) - ABIN181152 : Sato, Ozaki, Oh, Meguro, Hatanaka, Nagai, Muroi, Ozawa: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. in Blood 2006 (PubMed)

  10. Cow (Bovine) Polyclonal TGFB1 Primary Antibody for IF, IHC - ABIN2780306 : Cheon, Wei, Gurung, Youn, Bright, Poon, Whetstone, Guha, Alman: Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006 (PubMed)

More Antibodies against TGFB1 Interaction Partners

Rhesus Monkey Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. TGF-beta1 regulated pAKT (show AKT1 Antibodies) and IFNgamma expressions were associated with epithelial cell survival in rhesus macaque colon explants and suggest a potential role of mucosal TGF-beta1 in regulating intestinal homeostasis and EC integrity.

  2. These findings suggest that FBLN5 (show FBLN5 Antibodies) may interfere with choroidal neovascularization by downregulating VEGF (show VEGFA Antibodies), CXCR4 (show CXCR4 Antibodies), and TGFB1 expression and inhibiting choroidl endothelial cell proliferation.

  3. SIV infection of rhesus macaques results in the emergence of IL-17 (show IL17A Antibodies)-expressing cells during the acute phase. This subpopulation appears at day 14 postinfection concomitantly with an increase in TGF-beta and IL-18 (show IL18 Antibodies) expression.

  4. SIV-infected macaques exhibiting progression to AIDS displayed greater expression of TGF-beta and indoleamine 2,3 dioxygenase in CD8 (show CD8A Antibodies)+ T cells from mesentric lymph nodes.

Zebrafish Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. transforming growth factor beta (TGFbeta) is required for hematopoietic progenitor cell specification. The requirement for TGFbeta is two fold and sequential: autocrine via Tgfbeta1a and Tgfbeta1b produced in the endothelial cells themselves, followed by a paracrine input of Tgfbeta3 from the notochord, suggesting that the former programs the hemogenic endothelium and the latter drives endothelial-to-hematopoietic tran...

  2. The fine tuning of TGF-beta signaling derives from positive and negative control by Ldb2a (show LDB2 Antibodies).

  3. TGFbeta1a regulates zebrafish posterior lateral line formation via Smad5 (show SMAD5 Antibodies) mediated pathway.

  4. PCSK7 (show PCSK7 Antibodies) is essential for zebrafish development and regulates the expression and proteolytic cleavage of TGFbeta1a.

  5. TGFbeta signaling orchestrates the beneficial interplay between scar-based repair and cardiomyocyte-based regeneration to achieve complete heart regeneration.

  6. TGFbeta1 plays a role in zebrafish keratocyte migration.

  7. data presented show that Zili (show PIWIL2 Antibodies) suppresses TGF-beta signaling by physically associating with Smad4 (show SMAD4 Antibodies) and preventing the formation of Smad2 (show SMAD2 Antibodies)/3/4 and Smad1 (show SMAD1 Antibodies)/5/9/4 complexes

  8. TGF-beta1 acts at multiple sites, including LH receptor (show LHCGR Antibodies), 20beta-HSD (show HAL Antibodies) and membrane progestin receptor-beta (show PAQR8 Antibodies), to inhibit zebrafish oocyte maturation

  9. These data suggest Pez (show PTPN14 Antibodies) plays a crucial role in organogenesis by inducing TGFbeta and epithelial-mesenchymal transition.

  10. Data show that Rock2 (show ROCK2 Antibodies) acts as a negative regulator of the TGFbeta signaling pathway.

Xenopus laevis Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. These data indicate that TGF-beta signaling is crucial for the function of the transition zone, which in turn may affect the regulation of cilia length.

  2. R-Smads are the key components of TGFbeta beta signals in germ layer induction. SCP3 (show SYCP3 Antibodies) serves as a vegetally enriched, intrinsic factor (show GIF Antibodies) to ensure a prepared status of Smads for their activation.

  3. the present in vitro system, which permits not only the cell contraction-mediated cell sorting but also the TGF-b-directed mesodermal induction such as cartilage formation, may fairly reflect the embryogenesis in vivo.

  4. Loss of XTgfbi impaired blastopore formation and dorsal tissue morphogenesis.

  5. TGF-beta signaling has a role in nuclear localization of transcription factor Smad4 (show SMAD4 Antibodies)

  6. sortilin (show SORT1 Antibodies) negatively regulates TGF-beta signaling by diverting trafficking of precursor proteins to the lysosome during transit through the biosynthetic pathway

Human Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. In response to TGF-beta, RASSF1A (show RASSF1 Antibodies) is recruited to TGF-beta receptor I and targeted for degradation by the co-recruited E3 ubiquitin ligase (show MUL1 Antibodies) ITCH. RASSF1A (show RASSF1 Antibodies) degradation is necessary to permit Hippo pathway effector YAP1 (show YAP1 Antibodies) association with SMADs and subsequent nuclear translocation of receptor-activated SMAD2 (show SMAD2 Antibodies).

  2. RCCD1 as a novel regulator of TGF-beta-induced epithelial mesenchymal transformation and cell migration in non-small lung carcinoma cells.

  3. ASPP2 (show TP53BP2 Antibodies) suppresses invasion, peritoneal dissemination and TGF-beta1-induced EMT (show ITK Antibodies) by inhibiting Smad7 (show SMAD7 Antibodies) degradation mediated by ITCH in gastric cancer cells.

  4. These abnormalities are associated with increased transforming growth factor-b (show ATP5S Antibodies) signaling and defects in matrix metalloproteinase 9 (show MMP9 Antibodies) activity. Our data demonstrate that lamin A/C (show LMNA Antibodies) gene mutations responsible for FPLD2 (show LMNA Antibodies) and related lipodystrophies are associated with transforming growth factor-beta activation

  5. STAT3 (show STAT3 Antibodies) activation promotes ERBIN (show ERBB2IP Antibodies) expression and negatively regulates TGF-beta activity by the formation of a STAT3 (show STAT3 Antibodies)-ERBIN (show ERBB2IP Antibodies)-SMAD2 (show SMAD2 Antibodies)/3 complex.

  6. These studies support previously unrecognized, cooperative interaction between the CCN1 (show CCNA2 Antibodies) matricellular protein and canonical TGF-beta1/SMAD3 (show SMAD3 Antibodies) signaling that promotes lung fibrosis.

  7. Our data demonstrate that N-Cadherin (show CDH2 Antibodies) was markedly overexpressed and miR (show MLXIP Antibodies)-199b-5p was significantly downregulated in hepatocellular carcinoma (HCC (show FAM126A Antibodies)). MiR (show MLXIP Antibodies)-199b-5p exerts inhibitory effects on EMT (show ITK Antibodies), and directly targets N-cadherin (show CDH2 Antibodies) in HCC (show FAM126A Antibodies), supporting the potential utility of miR (show MLXIP Antibodies)-199b-5p as a promising strategy to treat HCC (show FAM126A Antibodies)

  8. Simvastatin attenuates the tumor-associated macrophage mediated gemcitabine resistance of PDAC by blocking the TGF-beta1/Gfi-1 axis.

  9. In hepatocellular carcinoma, TGFB1 expression most frequently correlates with a partial EMT (show ITK Antibodies), increase in mesenchymal genes and CD44 (show CD44 Antibodies) expression, as well as maintenance or over-expression of epithelial-related genes.

  10. c-Abl (show ABL1 Antibodies) promotes TGF-beta-induced SKIP/Smad3 (show SMAD3 Antibodies) interaction.

Pig (Porcine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. TGF-beta1-induced epithelial-myofibroblast plasticity is FAK (show PTK2 Antibodies)- dependent, whereas TGF-beta1-induced apoptosis is favored when FAK (show PTK2 Antibodies) signaling is inhibited.

  2. this study shows that TGF-beta1 protects intestinal integrity and influences Smad (show SMAD1 Antibodies) and MAPK (show MAPK1 Antibodies) signal pathways in intestinal epithelium cells after TNF-alpha (show TNF Antibodies) challenge

  3. this study shows that anemonin may ameliorate LPS (show IRF6 Antibodies)-induced intestinal injury and improve restoration by regulating the TGF-b1 and EGFR (show EGFR Antibodies) signaling pathways

  4. The results indicated that TGF-beta-1 was associated with the restoration of intestinal morphology and barrier function following weaning stress.

  5. Data (including data from in vitro and in vivo experiments) suggest that day 14 elongated conceptus secretes proteins that up-regulate TGFbeta1 mRNA and TGFbeta1 expression in endometrium; TGFbeta1 may be important during pregnancy maintenance.

  6. The effects of semen, spermatozoa in extender, or extender alone on the expression of TGF-beta1, IL-10 (show IL10 Antibodies), and IL-6 (show IL6 Antibodies) in ovarian follicles are reported.

  7. Dietary (1,3/1,6)-beta-D-glucan reduced the mRNA expression of transforming growth factor (TGF) beta2 (show TGFB2 Antibodies) and tended to reduce the mRNA expression of TGF-beta1 in lung tissue of neonatal piglet.

  8. TGF-beta1, via TGF-beta1 receptor I and p38 MAPK (show MAPK14 Antibodies) signaling, reduces CFTR (show CFTR Antibodies) expression to impair CFTR (show CFTR Antibodies)-mediated anion secretion, which would likely compound the effects associated with mild CFTR (show CFTR Antibodies) mutations and ultimately would compromise male fertility.

  9. High yield isolation of BMP-2 (show BMP2 Antibodies) from bone and in vivo activity of a combination of BMP-2 (show BMP2 Antibodies)/TGF-beta1.

  10. Boar seminal plasma contained TGF- beta1 and IL-10 (show IL10 Antibodies) but with high individual variation.

Cow (Bovine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Taken together, Staphylococcus aureus induces TGF-beta1 and bFGF (show FGF2 Antibodies) expression through the activation of AP-1 (show JUN Antibodies) and NF-kappaB (show NFKB1 Antibodies) in bovine mammary gland fibroblasts.

  2. The results identify TGFB1 and ESRRA (show ESRRA Antibodies) as likely transcriptional regulators of rumen epithelial development and energy metabolism, respectively, and provide targets for modulation of rumen development and function in the growing calf.

  3. the combined treatment with TGF-beta1 and BMP-7 (show BMP7 Antibodies) or treatment first with TGF-beta1 followed by BMP-7 (show BMP7 Antibodies) was more effective than other treatment groups in both chondrogenic differentiation and SZP (show PRG4 Antibodies) secretion.

  4. Tenascin-X (show TNXB Antibodies) promotes activation of latent TGF-beta1 and subsequent epithelial to mesenchymal transition in mammary epithelial cells.

  5. a detailed computational model for TGF-beta signalling that incorporates elements of previous models together with crosstalking between Smad1 (show SMAD1 Antibodies)/5/8 and Smad2 (show SMAD2 Antibodies)/3 channels through a negative feedback loop dependent on Smad7 (show SMAD7 Antibodies).

  6. Endogenous TGF-beta1 became more bioactive following activation of the transgene protein product in chondrocytes.

  7. A novel peptide, P2K, regulating TGF-beta1 signaling had an anabolic effect on bovine intervertebral disc cells and rabbit degenerated discs.

  8. Data show that TGF-beta pathways operate during ovarian fetal development, and fibrillin 3 (show FBN3 Antibodies) is highly expressed at a critical stage early in developing human and bovine fetal ovaries.

  9. Role of TGF-beta1 and TNF-alpha (show TNF Antibodies) in IL-1beta (show IL1B Antibodies) mediated activation of proMMP-9 in pulmonary artery smooth muscle cells: involvement of an aprotinin sensitive protease.

  10. vascular endothelial growth factor indirectly stimulates smooth muscle cell proliferation and migration through the modulation of basic fibroblast growth factor (show FGF2 Antibodies) and transforming growth factor beta(1) released by endothelial cells

Mouse (Murine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Studied endothelial cell-specific activation of TGF-beta signaling in tissue fibrosis and vasculopathy. Constitutive TGFbeta-1 signaling in endothelial cells resulted in cutaneous and visceral fibrosis.

  2. data show that the combination of cell lineage, immune mediators and both dietary and microbe-derived environmental factors shape intestinal dendritic cells into critical gatekeepers of TGF-beta-dependent immune responses through regulation of beta8 integrin expression

  3. Study found that transforming growth factor-beta (TGF-beta) is an upstream regulator of vascular endothelial growth factor (VEGF), whereas VEGF pathway activity does not alter the TGF-beta pathway in vitro.

  4. overexpression of Fam3c (show FAM3C Antibodies) caused reduction of Runx2 (show RUNX2 Antibodies) expression at both mRNA and protein levels. Fam3c (show FAM3C Antibodies) was localized in the cytoplasm and it was not secreted outside the cell during osteoblast differentiation and therefore, may function intracellularly. Furthermore, Fam3c (show FAM3C Antibodies) and TGF-beta1 were found to regulate each other reciprocally

  5. this study shows that the presence of IFN-alpha (show IFNA Antibodies) at antigen sensitization activates an IDO1 (show IDO1 Antibodies)/TGF-beta-dependent anti-inflammatory program that upon antigenic rechallenge prevents inflammation via plasmacytoid dendritic cells

  6. We show that astrocytes prevent synapse loss induced by AbetaOs, via production of transforming growth factor-beta1 (TGF-beta1). We found that AbetaOs trigger morphological and functional alterations in astrocytes, and impair their neuroprotective potential.

  7. this study shows that sodium benzoate induces the expression of TGF-beta in splenocytes and alleviates experimental allergic encephalomyelitis via the STAT6 (show STAT6 Antibodies)-TGF-beta-Treg pathway

  8. IL-33 (show IL33 Antibodies) receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 (show CD4 Antibodies) T cell proliferation through IL-10 (show IL10 Antibodies) and TGFbeta release.

  9. triptolide enhances the suppressive effects of Tregs on osteoclast differentiation and bone resorption by enhancing the secretion of IL-10 (show IL10 Antibodies) and TGF-beta1

  10. Cav-1 (show CAV1 Antibodies) depletion, oxidative stress-mediated reduction in BMPRII (show BMPR2 Antibodies) expression, and enhanced TGF-beta-driven SMAD-2 (show SMAD2 Antibodies)/3 signaling promote pulmonary vascular remodeling in inflamed lungs.

Rabbit Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Data indicate that cardiac contractility modulation (CCM) therapy exerted protective effects against myocardial fibrosis potentially by inhibiting TGF-beta1/Smad3 (show SMAD3 Antibodies) signaling pathway in chronic heart failure .

  2. study suggested that TGF-beta1/Smad3/smad7 is a major pathway which plays an important role in the regulation of the IUA and specific inhibitor of Smad3 (SIS3) may provide a new therapeutic strategy for IUA.

  3. cell therapy promoted TGF-beta1 expression in nucleus pulposus, leading to anti-inflammatory effects via the inhibition of NF-kappaB (show NFKB1 Antibodies), and the amelioration of disc degradation.

  4. that prenatal tracheal occlusion increases TGF-beta/Rho kinase (show ROCK1 Antibodies) pathway, myofibroblast differentiation, and matrix deposition in neonatal rabbit and human congenital diaphragmatic hernia lungs

  5. observation. Based on the above results, we conclude that TGF-beta1-immobilized PLGA-gelatin scaffold seeded with ASCs considerably enhances the quality of the tissue-engineered cartilage, therefore, advancing the field of cartilage tissue engineering

  6. Smad7 (show SMAD7 Antibodies) plays a crucial role in antagonizing epithelial-mesenchymal transition induced by TGFbeta signaling and is a Notch (show NOTCH1 Antibodies) signaling target in limbal epithelial stem cells.

  7. the role of IL-10 in inhibited allograft rejection may be associated with CD4+CD25+ regulatory T cells and IL-10, and may be independent of TGF-b

  8. After NOTCH1 (show NOTCH1 Antibodies) knockdown and TGFB1 stimulation, rabbit mesenchymal stem cells expressed higher levels of proteoglycan (show Vcan Antibodies) and collagen II.

  9. TGF-beta1 gene transcription significantly correlates with the surgical vaginal and dermal wound closure rate.

  10. A novel peptide, P2K, regulating TGF-beta1 signaling had an anabolic effect on bovine intervertebral disc cells and rabbit degenerated discs.

Guinea Pig Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. TGF beta is involved in the pathogenesis of tympanosclerosis.

  2. There was significantly higher expression of TGF-beta1 and MMP-9 (show MMP9 Antibodies) in nasal mucosa of experimental allergic rhinitis guinea pigs than in controls.

Horse (Equine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Within the limitations of the study design, production of COMP (show COMP Antibodies) during healing of skin wounds does not appear to be influenced by wound type or anatomic site, nor does it appear to be correlated with TGF-beta1 concentrations.

  2. Peritoneal TGF-beta(1) concentration was higher in horses with severe gastrointestinal diseases, in horses with an altered peritoneal fluid, and in nonsurvivors.

TGFB1 Antigen Profile

Antigen Summary

This gene encodes a member of the transforming growth factor beta (TGFB) family of cytokines, which are multifunctional peptides that regulate proliferation, differentiation, adhesion, migration, and other functions in many cell types. Many cells have TGFB receptors, and the protein positively and negatively regulates many other growth factors. The secreted protein is cleaved into a latency-associated peptide (LAP) and a mature TGFB1 peptide, and is found in either a latent form composed of a TGFB1 homodimer, a LAP homodimer, and a latent TGFB1-binding protein, or in an active form composed of a TGFB1 homodimer. The mature peptide may also form heterodimers with other TGFB family members. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease.

Alternative names and synonyms associated with TGFB1

  • transforming growth factor, beta 1 (TGFB1) antibody
  • transforming growth factor, beta 1a (tgfb1a) antibody
  • transforming growth factor, beta-induced, 68kDa (TGFBI) antibody
  • transforming growth factor, beta-induced, 68kDa (tgfbi) antibody
  • transforming growth factor, beta-induced, 68kDa (LOC100227786) antibody
  • transforming growth factor beta 1 (TGFB1) antibody
  • transforming growth factor, beta 1 (Tgfb1) antibody
  • transforming growth factor, beta 1 (tgfb1) antibody
  • transforming growth factor, beta 1 (tgf) antibody
  • ai39657 antibody
  • betaig-h3 antibody
  • bigh3 antibody
  • cdb1 antibody
  • cdg2 antibody
  • cdgg1 antibody
  • ced antibody
  • csd antibody
  • csd1 antibody
  • csd2 antibody
  • csd3 antibody
  • dpd1 antibody
  • ebmd antibody
  • lap antibody
  • lcd1 antibody
  • MGC146225 antibody
  • tgf antibody
  • tgf-beta antibody
  • TGF-BETA-1 antibody
  • TGF-beta1 antibody
  • TGF-beta5 antibody
  • tgfb antibody
  • Tgfb-1 antibody
  • TGFB1 antibody
  • TGFB4 antibody
  • tgfb5 antibody
  • tgfbeta antibody
  • TGFbeta1 antibody
  • TGFBI antibody
  • wu:fb13a07 antibody
  • xx:ai39657 antibody

Protein level used designations for TGFB1

transforming growth factor beta1 , transforming growth factor, beta 1 , transforming growth factor, beta-induced, 68kDa , transforming growth factor-beta-induced protein ig-h3-like , transforming growth factor beta-1-like , TGF-beta-1 , transforming growth factor beta 4 , transforming growth factor beta-1 , TGF-beta 1 protein , latency-associated peptide , transforming growth factor, beta 1 (Camurati-Engelmann disease) , transforming growth factor-beta-1 , TGF-beta 1 , transforming growth factor-beta 1 , transforming growth factor, beta-1 , transforming growth factor beta 1 , regulatory protein , transforming growth factor-beta , TGF-beta-5 , tgf beta , tgf-beta 5 , transforming gorwth factor-Beta5 , transforming growth factor-B5 , transforming growth factor-beta 5 , Transforming growth factor beta-1

GENE ID SPECIES
574135 Macaca mulatta
359834 Danio rerio
768263 Felis catus
456060 Pan troglodytes
462081 Pan troglodytes
481519 Canis lupus familiaris
495971 Xenopus laevis
712503 Macaca mulatta
779782 Xenopus (Silurana) tropicalis
100227786 Taeniopygia guttata
100397340 Callithrix jacchus
100401979 Callithrix jacchus
100441300 Pongo abelii
100459982 Pongo abelii
100580274 Nomascus leucogenys
100581386 Nomascus leucogenys
100873157 Gallus gallus
7040 Homo sapiens
397078 Sus scrofa
443417 Ovis aries
59086 Rattus norvegicus
403998 Canis lupus familiaris
282089 Bos taurus
21803 Mus musculus
100008645 Oryctolagus cuniculus
100135628 Cavia porcellus
100033900 Equus caballus
397778 Xenopus laevis
100136774 Oncorhynchus mykiss
Selected quality suppliers for anti-TGFB1 (TGFB1) Antibodies
Did you look for something else?